ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

STX Shield Therapeutics Plc

1.075
-0.25 (-18.87%)
Last Updated: 10:19:44
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -18.87% 1.075 1.05 1.10 1.325 1.075 1.33 3,076,199 10:19:44
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.25 10.24M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.33p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £10.24 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.25.

Shield Therapeutics Share Discussion Threads

Showing 5826 to 5847 of 23175 messages
Chat Pages: Latest  243  242  241  240  239  238  237  236  235  234  233  232  Older
DateSubjectAuthorDiscuss
15/5/2020
16:06
Some investors probably got scared out of this now due to how it can swing by so much i.e. 200p to 50p. Hopefully only positive news from now on
78steve
15/5/2020
14:07
Do you think they want that hearing out of the way on 23rd June so as not to put a dampener on it perhaps? I believe it's not related to US or China only Europe, but nonetheless could have some impact..
daveboy1
15/5/2020
13:43
can't believe we haven't seen a steady rise this week. I've got loads of these but have done 2 further top ups this week in anticipation of a US deal in the next month or so IMHO.

Anything under £1.50 is a massive bargain based on size of US market and imminent deal.

Last few RNSs have dropped the hints that this is not too far away

shandypants2
15/5/2020
10:08
Yes, just briefed my son on them in case I've lost my marbles by the time there is any action of a positive nature !!
daveboy1
15/5/2020
09:26
All good things come to those that wait

And wait !!!

peachie 74
15/5/2020
08:21
Looks like another thriller in store for us here today.
daveboy1
14/5/2020
09:08
Mentioned again on the radio it will be months before normal hospital procedures can recommence, including cancer treatment and surgery. So where will IV iron infusions be ? Non existent or severely limited for a long time to come. Surely Feraccru has had to benefit here..

And once people try it, I’m sure they won’t be rushing back to IV

peachie 74
13/5/2020
10:03
Ah,rapture, another gardening day. Although immaculate already !
daveboy1
12/5/2020
14:20
Agreed - hopefully some good news arriving this quarter.
Incidentally, LSE has nearly twice as many shares bought than sold!

daveboy1
12/5/2020
13:48
Yes. MMS playing games. No volume and they aren’t bothered. People who have researched this will know just how massive this could be. Hence no real selling.
Not many shares in PI hands.
It’s just going to need something to spark interest ( ie US deal ) to get people into the share, research it and see how the US deal will just be the start hopefully

Iron deficiency is massive worldwide.
IV iron has so many limitations.
These tablets can take over a billion dollar market if guided right. Fingers crossed for the holders.

peachie 74
12/5/2020
11:15
It goes down 7.5p on less sells than yesterday's buys when it moved 0.5p up on the bell. Curious.
daveboy1
11/5/2020
16:17
"US licensing deal: Although stepping down, the founder and former CEO has agreed to support the licensing process in the US so that the current positive momentum is not lost. We understand that there is a strong shortlist of potential partners."

Strong shortlist of potential partners sounds promising too

peachie 74
11/5/2020
15:06
Yes they say US commercialisation deal on 2 months..tick tock!
ny boy
11/5/2020
14:56
New trading update from Hardman Research
peachie 74
07/5/2020
13:00
How do you know they have no plan to replace them ?
Did I miss that in the RNS ? Tim Watts could well fulfill the role well. He may be temporary. None of that info will be in the public domain.
Or are we treading water until a takeover ?

peachie 74
07/5/2020
12:45
>> cranky man

Good point. It does make you wonder what the future plan is....

nobbygnome
07/5/2020
12:35
No CEO no Medical Director . No plan to replace them. It’s just about sweating this asset. They don’t need these medical or commercial guys anymore. It’s a holding company for Feraccru. No problem for me.
crankyman
07/5/2020
12:16
I’d rather it be stuck here than in the 80s like it was not along ago though !

Returning to the point of winding down as a development company, Feraccru and PT20 have been the main 2 developments for ever basically. They have more than enough meat on the bone with these 2 products. They have never been a developer of new products ??

peachie 74
07/5/2020
12:11
Don’t you just love these MM’s, keep the spread wide and the bid low to try and mug a few more investors jeez! Lolz
ny boy
07/5/2020
12:06
Yep, interesting perspective! Seems like share price stuck in a rut atm though.
daveboy1
07/5/2020
10:15
Winding down. Really ?!
Is the push in China winding down
US deal winding down !
PT20 development winding down !
Covid related delay on paediatrics winding down !?

You after some cheaper shares Cranky !

peachie 74
07/5/2020
09:16
I wouldn't spend too much time dissecting these scripted interviews. He even said "readers" when he should have said "viewers". It's just another holding statement. I'm sure he's reasonably competent. Both medical director and CEO have gone. Paediatric study on hold. This company is winding down as a development organisation. Fair enough. They did amazingly well. Tiny slip up at the end.
crankyman
Chat Pages: Latest  243  242  241  240  239  238  237  236  235  234  233  232  Older

Your Recent History

Delayed Upgrade Clock